Cite
HARVARD Citation
McLaughlin, V. et al. (n.d.). UNISUS study design: a phase 3 superiority study comparing the efficacy, safety, and tolerability of macitentan 75 mg vs macitentan 10 mg in patients with pulmonary arterial hypertension (PAH). European heart journal. p. . [Online].